PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Kidney function monitoring vital for people on lithium

2014-11-14
(Press-News.org) People with bipolar disorder who are being treated with the drug lithium are at risk of acute kidney damage and need careful monitoring, according to new research from the University of East Anglia (UEA) and Norfolk and Suffolk NHS Foundation Trust.

Lithium is a mainstay treatment for bipolar disorder and it is known that the drug can cause a loss of kidney function. The new research establishes the link between short-term exposure to high levels and potential damage to the kidneys.

It is still not known what the impact of more than a single exposure to high levels can have on kidney function. The Norfolk team are currently exploring the effects of multiple exposures to high lithium levels.

Researchers from UEA's School of Pharmacy and Norwich Medical School and pharmacists at Norfolk and Suffolk NHS Foundation Trust undertook a retrospective analysis of 699 Norfolk people registered on the Norfolk SystemTDM® database who have received lithium over the past 10 years.

The results show for the first time that a single high level of lithium (>1.0mmol/L) is associated with a significant decrease in filtration by the kidneys following excessive lithium exposure. Kidney function remained affected for up to nine months after exposure to a high lithium level.

Norfolk has had a county-wide lithium database and register (SystemTDM®) since 2002. The database has significantly improved rates of lithium testing and monitoring and has helped NHS services in the county to exceed national standards of care for people taking lithium.

The study analysed the SystemTDM® register to look at measures of kidney function in the three months following a high level of lithium being detected (>1.0mmol/L) when compared to people whose lithium levels never exceeded 0.8mmol/L.

Recently NICE changed its recommendation that lithium levels should be carried out every six months, a reduction from previously recommending lithium levels every three months. These results strongly support lithium level monitoring be undertaken at least every three months, in line with other UK guidelines and not be reduced.

Lead researcher Emma Kirkham from UEA's School of Pharmacy said: "Our analysis shows for the first time that a single exposure to a lithium level greater than 1.0mmol/L is associated with an increased risk of kidney function impairment in the following three months and that the higher the level, the greater the effect."

"This highlights the need for regular monitoring undertaken at least every three months, and that monitoring should not be reduced further until the impact of more than one high-level of lithium has been fully established."

Professor Steve Bazire, consultant pharmacist, Norfolk and Suffolk NHS Foundation Trust, said: "The research shows why the care provided in Norfolk by NSFT through SystemTDM® is a benchmark for the rest of the UK. SystemTDM® has challenged the idea that less frequent testing of lithium may be safe. The level of care provided in Norfolk to patients taking lithium should be the norm across the country and not the exception."

INFORMATION:

'One lithium level >1.0 mmol/L causes an acute decline in eGFR: findings from a retrospective analysis of a monitoring database' is published in the journal BMJ Open.



ELSE PRESS RELEASES FROM THIS DATE:

DNA sequencing helps identify genetic defects in glaucoma

2014-11-14
Scientists from the University of Liverpool have sequenced the mitochondrial genome in glaucoma patients to help further understanding into the genetic basis for the disease. Glaucoma is a major cause of irreversible blindness, affecting more than 60 million people worldwide, increasing to an estimated 79.6 million people by 2020. It is thought that the condition has genetic origins and many experiments have shown that new sequencing approaches could help understand how the condition develops. Studies on primary open-angle glaucoma - the most common form of glaucoma ...

New insight into common cause of blindness

2014-11-14
Age-related Macular Degeneration (AMD) is the major cause of blindness in the western world, affecting around 50 million people. It has been shown that sufferers are genetically predisposed to develop the condition. One of the most important risk associated genes is called complement factor H (CFH). This encodes a protein called factor H (FH) that is responsible for protecting our eyes from attack by part of our immune system, called the complement system. FH achieves this by sticking to tissues, and when it is present in sufficient quantities it prevents the complement ...

New mechanism for growth control discovered

New mechanism for growth control discovered
2014-11-14
Animal growth is closely regulated by environmental factors such as nutrition. If the nutrition of a growing animal is limited, growth slows down and the eventual size of the animal remains smaller. Insulin-like signaling plays a key role in coordinating growth in response to dietary status in multicellular animals. Doctoral student Kiran Hasygar and Assistant Professor Ville Hietakangas from the Department of Biosciences and Institute of Biotechnology, University of Helsinki, Finland, have now uncovered a new regulatory mechanism coordinating animal growth in response ...

Conventional therapies are less efficient in cancer patients carrying 'BRCA' mutations

Conventional therapies are less efficient in cancer patients carrying BRCA mutations
2014-11-14
Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy - and they also have a lower survival rate than those who are non-carriers of these genetic mutations. Data from the study, which has been published in the journal European Urology, points to the need for new clinical trials aimed at targeting these mutations in order to tailor treatment for these patients. The study has been led by David Olmos and Elena Castro at the Spanish National Cancer Research Centre (CNIO) ...

Expression of SIP1 protein indicates poor prognosis in pharyngeal cancer

2014-11-14
The expression of SIP1 protein in pharyngeal squamous cell carcinoma tumours often indicates an advanced tumour stage, a high risk of recurrence and a poor prognosis, according to research from the University of Eastern Finland. Based on the results, SIP1 is a potential new prognostic factor for clinical use, helping to single out patients with more aggressive tumour behaviour requiring more intensive therapy and closer follow-up. Ms Anna Jouppila-Mättö, MD, presented the results in her doctoral thesis. Although pharyngeal squamous cell carcinoma (PSCC) is a ...

HIV risks high in Mexico City's male sex trade

HIV risks high in Mexico Citys male sex trade
2014-11-14
PROVIDENCE, R.I. [Brown University] -- A new study documents the stark health dangers of the male sex trade in the streets, hotels, and discotheques of Mexico City. Lead author and health economist Omar Galárraga's point in making the grim assessment of the legal but perilous market is to find an incentive that might reduce the spread of HIV and other diseases in the nation's community of men who have sex with men. "It's a very highly at-risk population," said Galárraga, assistant professor of health services, policy and practice in the Brown University School ...

New form of crystalline order holds promise for thermoelectric applications

New form of crystalline order holds promise for thermoelectric applications
2014-11-14
Since the 1850's scientists have known that crystalline materials are organized into fourteen different basic lattice structures. However, a team of researchers from Vanderbilt University and Oak Ridge National Laboratory (ORNL) now reports that it has discovered an entirely new form of crystalline order that simultaneously exhibits both crystal and polycrystalline properties, which they describe as "interlaced crystals." Writing in the Nov. 14 issue of the journal Nature Communications, the researchers describe finding this unusual arrangement of atoms while studying ...

Mission to discover hundreds of black holes could unlock secrets of the Universe

2014-11-14
A team of Cardiff University researchers have made a breakthrough in helping scientists discover hundreds of black holes throughout the universe. When two detectors are switched on in the US next year, the Cardiff team hope their research will help scientists pick up the faint ripples of black hole collisions millions of years ago, known as gravitational waves. Black holes cannot be seen, but scientists hope the revamped detectors - which act like giant microphones - will find remnants of black hole collisions. Led by Dr Mark Hannam from the School of Physics and Astronomy, ...

Killing cancer by protecting normal cells

2014-11-14
(PHILADELPHIA) - Although radiation treatments have become much more refined in recent years, it remains a challenge to both sufficiently dose the tumor while sparing the surrounding tissue. A new anti-cancer drug, already in clinical development, may help address this issue by protecting normal cells - but not the cancer - from the effects of radiation. The research, published November 14th in Molecular Cancer Therapeutics, further suggests this drug may also be useful in treating accidental exposure to radiation. "It was a stroke of luck that the drug that most effectively ...

Nonsmokers in automobiles are exposed to significant secondhand smoke

2014-11-14
Nonsmokers sitting in an automobile with a smoker for one hour had markers of significantly increased levels of carcinogens and other toxins in their urine, indicating that secondhand smoke in motor vehicles poses a potentially major health risk according to a groundbreaking study led by UC San Francisco researchers. The nonsmoking passengers showed elevated levels of butadiene, acrylonitrile, benzene, methylating agents and ethylene oxide. This group of toxic chemicals is "thought to be the most important among the thousands in tobacco smoke that cause smoking-related ...

LAST 30 PRESS RELEASES:

Marshall University, Intermed Labs announce new neurosurgical innovation to advance deep brain stimulation technology

Preclinical study reveals new cream may prevent or slow growth of some common skin cancers

Stanley Family Foundation renews commitment to accelerate psychiatric research at Broad Institute

What happens when patients stop taking GLP-1 drugs? New Cleveland Clinic study reveals real world insights

American Meteorological Society responds to NSF regarding the future of NCAR

Beneath Great Salt Lake playa: Scientists uncover patchwork of fresh and salty groundwater

Fall prevention clinics for older adults provide a strong return on investment

People's opinions can shape how negative experiences feel

USC study reveals differences in early Alzheimer’s brain markers across diverse populations

300 million years of hidden genetic instructions shaping plant evolution revealed

High-fat diets cause gut bacteria to enter brain, Emory study finds

Teens and young adults with ADHD and substance use disorder face treatment gap

Instead of tracking wolves to prey, ravens remember — and revisit — common kill sites

Ravens don’t follow wolves to dinner – they remember where the food is

Mapping the lifelong behavior of killifish reveals an architecture of vertebrate aging

Designing for hard and brittle lithium needles may lead to safer batteries

Inside the brains of seals and sea lions with complex vocal behavior learning

Watching a lifetime in motion reveals the architecture of aging

Rapid evolution can ‘rescue’ species from climate change

Molecular garbage on tumors makes easy target for antibody drugs

New strategy intercepts pancreatic cancer by eliminating microscopic lesions before they become cancer

Embryogenesis in 4D: a developmental atlas for genes and cells

CNIO research links fertility with immune cells in the brain

Why do lithium-ion batteries fail? Scientists find clues in microscopic metal 'thorns'

Surface treatment of wood may keep harmful bacteria at bay

Carsten Bönnemann, MD, joins St. Jude to expand research on pediatric catastrophic neurological disorders

Women use professional and social networks to push past the glass ceiling

Trial finds vitamin D supplements don’t reduce covid severity but could reduce long COVID risk

Personalized support program improves smoking cessation for cervical cancer survivors

Adverse childhood experiences and treatment-resistant depression

[Press-News.org] Kidney function monitoring vital for people on lithium